Sri Lanka releases 18 Indian fishermen

Agencies

June 15, 2019

Colombo, Jun 15: Sri Lanka has released 18 Indian fishermen arrested for illegally fishing in the Sri Lankan waters, an official said on Saturday.

The fishermen, who were held off the coast of Point Pedro two months ago by the Sri Lankan Navy, were freed by a court here on Friday.

"They are now to be handed over to the immigration officials for repatriation to India," the official said.

Illegal fishing by Indians in the Sri Lankan waters have been a recurring problem and has figured at high-level talks between the two neighbours.

However, the Navy says there has been a marked decrease in the number of cases compared to a few years ago.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments